Search Results - "HENAULT, L. E."

Implications of Stroke risk criteria on the anticoagulation decision in nonvalvular Atrial Fibrillation: The anticoagulation and risk factors in Atrial Fibrillation (ATRIA) Study by GO, A. S, HYLEK, E. M, PHILLIPS, K. A, BOROWSKY, L. H, HENAULT, L. E, CHANG, Y, SELBY, J. V, SINGER, D. E

“…Warfarin dramatically reduces the risk of stroke in patients with nonvalvular atrial fibrillation (NVAF) but increases the likelihood of bleeding. Accurately…”
Get full text

Warfarin for atrial fibrillation in community‐based practise by ROSE, A. J., OZONOFF, A., HENAULT, L. E., HYLEK, E. M.

“…Background: Previous studies of anticoagulation for atrial fibrillation (AF) have predominantly occurred in academic settings or randomized trials, limiting…”
Get full text

IL-4 Enhances IL-10 Gene Expression in Murine Th2 Cells in the Absence of TCR Engagement by Schmidt-Weber, C. B, Alexander, S. I, Henault, L. E, James, L, Lichtman, A. H

“…Both IL-4 and IL-10 are regulatory cytokines produced by Th2 cells that can down-regulate cell-mediated immune responses. The studies reported here examine the…”
Get full text

Prevalence of Diagnosed Atrial Fibrillation in Adults: National Implications for Rhythm Management and Stroke Prevention: the AnTicoagulation and Risk Factors In Atrial Fibrillation (ATRIA) Study by Go, Alan S, Hylek, Elaine M, Phillips, Kathleen A, Chang, YuChiao, Henault, Lori E, Selby, Joe V, Singer, Daniel E

“…CONTEXT Atrial fibrillation is the most common arrhythmia in elderly persons and a potent risk factor for stroke. However, recent prevalence and projected…”
Get full text

Warfarin dose management affects INR control by ROSE, A. J., OZONOFF, A., BERLOWITZ, D. R., HENAULT, L. E., HYLEK, E. M.

“…Background: Little is known about how patterns of warfarin dose management contribute to percentage time in the therapeutic International Normalized Ratio…”
Get full text

Anticoagulation for valvular heart disease in community-based practice by Rose, A J, Ozonoff, A, Henault, L E, Hylek, E M

“…Little is known about patients who receive oral anticoagulation for valvular heart disease (VHD) in community-based practice. It was this study's objective to…”
Get more information

Human endothelial cell costimulation of T cell IFN-gamma production by Briscoe, DM, Henault, LE, Geehan, C, Alexander, SI, Lichtman, AH

“…In this report, we show that human endothelial cells (EC) provide costimulatory signals to mitogen-activated CD4+ T cells to augment IFN-gamma production. We…”
Get full text

Translating the results of randomized trials into clinical practice : The challenge of warfarin candidacy among hospitalized elderly patients with atrial fibrillation by HYLEK, Elaine M, D'ANTONIO, James, EVANS-MOLINA, Carmella, SHEA, Carol, HENAULT, Lori E, REGAN, Susan

“…Numerous studies have documented under use of warfarin particularly among elderly patients. A better understanding of the discrepancy between trials and…”
Get full text

Gender differences in the risk of ischemic stroke and peripheral embolism in atrial fibrillation : The anticoagulation and risk factors in atrial fibrillation (ATRIA) study by FANG, Margaret C, SINGER, Daniel E, CHANG, Yuchiao, HYLEK, Elaine M, HENAULT, Lori E, JENSVOLD, Nancy G, GO, Alan S

“…Previous studies provide conflicting results about whether women are at higher risk than men for thromboembolism in the setting of atrial fibrillation (AF). We…”
Get full text

Effect of Intensity of Oral Anticoagulation on Stroke Severity and Mortality in Atrial Fibrillation by Hylek, Elaine M, Go, Alan S, Chang, Yuchiao, Jensvold, Nancy G, Henault, Lori E, Selby, Joe V, Singer, Daniel E

“…In a large cohort of patients with nonvalvular atrial fibrillation, oral anticoagulation with warfarin that resulted in an international normalized ratio (INR)…”
Get full text

Anticoagulation Therapy for Stroke Prevention in Atrial Fibrillation: How Well Do Randomized Trials Translate Into Clinical Practice? by Go, Alan S, Hylek, Elaine M, Chang, Yuchiao, Phillips, Kathleen A, Henault, Lori E, Capra, Angela M, Jensvold, Nancy G, Selby, Joe V, Singer, Daniel E

“…CONTEXT Warfarin has been shown to be highly efficacious for preventing thromboembolism in atrial fibrillation in randomized trials, but its effectiveness and…”
Get full text

Factor V Leiden and risk of ischemic stroke in nonvalvular atrial fibrillation: The anticoagulation and risk factors in Atrial fibrillation (ATRIA) study by GO, Alan S, REED, Guy L, HYLEK, Elaine M, PHILLIPS, Kathleen A, LIN LIU, HENAULT, Lori E, SELBY, Joe V, SINGER, Daniel E

“…Atrial fibrillation is a major cause of cardioembolic stroke. Since atrial and venous pressures are similar, genetic variants that promote venous…”
Get full text

Challenges to the effective use of unfractionated heparin in the hospitalized management of acute thrombosis by Hylek, Elaine M, Regan, Susan, Henault, Lori E, Gardner, Margaret, Chan, Andrew T, Singer, Daniel E, Barry, Michael J

“…Unfractionated heparin therapy is care intensive because of dose-response variability, and because of the necessity of constant intravenous infusion and…”
Get more information